Volume 8, Issue 5
Forewordp. 457
Alzheimer\'s disease therapy: a moving target
Author(s): Rudy J Castellani, Xiongwei Zhu and George Perry
Editorialp. 459
Why age (and timing) really matters in developing drugs for neurodegenerative disease
Author(s): Dave Morgan and Amanda G Smith
Editorialp. 463
The vasculature in Alzheimer\'s disease: a new therapeutic target for an old disease?
Author(s): Paula Grammas
News and Viewsp. 467
Alzheimer\'s Disease
Research Highlightsp. 471
Highlights from the latest articles in Alzheimer\'s disease
Author(s): Jesus Avila and Carmen Laura Sayas
Review Articlep. 475
Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs
Author(s): Rudy J Castellani, Hyoung-gon Lee, Robert B Petersen, Xiongwei Zhu and George Perry
Review Articlep. 481
Repositioning leptin as a therapy for Alzheimer\'s disease
Author(s): Jane M Johnston, Steven J Greco, Ashkan Hamzelou, J Wesson Ashford and Nikolaos Tezapsidis
Perspectivep. 491
Current and future treatments of memory complaints and Alzheimer\'s disease
Author(s): William K Summers
Editorialp. 507
Progenitor cell therapies as a novel treatment for traumatic brain injury: a pathway towards neuroprotection
Author(s): Peter A Walker, Shinil K Shah and Charles S Cox Jr
Appendicesp. 581
Acknowledgement: Volume 8 Issue 5
Appendicesp. 582
Author guidelines: Volume 8 Issue 5
Review Articlep. 569
The spectrum of albuminuria as a predictor of cardiorenal outcomes
Author(s): Ivana Lazich, and George L Bakris
Review Articlep. 563
Antimalarial drug combination chemotherapy in malaria case management in Tanzania: how did it come about?
Author(s): Stephen ED Nsimba
Research Articlep. 555
Rebound tonometry for the measurement of intraocular pressure and its relation with gender and refractive errors in Mozambique
Author(s): Javier Ruiz-Alcocer, David Madrid-Costa, Caridad Perez-Vives, Santiago Garcia-Lazaro and Jorge Jorge
Research Articlep. 545
Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
Author(s): Shah-Jalal Sarker, Abu Nayeem Chowdhury, Zahid Hussain, AKM Mosharrof Hossain and Hashem Chowdhury
Review Articlep. 527
Tenofovir in the treatment of chronic hepatitis B
Author(s): Derek Yu and Jenny Heathcote
